{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:56:49Z","timestamp":1723060609984},"reference-count":52,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2019.10021","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T08:27:58Z","timestamp":1552552078000},"source":"Crossref","is-referenced-by-count":4,"title":["Knockdown of serpin peptidase inhibitor clade C member\ufffd1 inhibits the growth of nasopharyngeal carcinoma cells"],"prefix":"10.3892","author":[{"given":"Jin","family":"Xu","sequence":"first","affiliation":[{"name":"Department of ENT, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoyun","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of ENT, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of ENT, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"key20200713232400_b1-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"key":"key20200713232400_b2-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/1097-0142(19830715)52:2<362::AID-CNCR2820520230>3.0.CO;2-V","article-title":"Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy","volume":"52","author":"Hsu","year":"1983","journal-title":"Cancer"},{"key":"key20200713232400_b3-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1016\/j.febslet.2014.08.021","article-title":"MicroRNA-320a inhibits cell proliferation, migration and invasion by targeting BMI-1 in nasopharyngeal carcinoma","volume":"588","author":"Qi","year":"2014","journal-title":"FEBS Lett"},{"key":"key20200713232400_b4-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J","article-title":"Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation","volume":"61","author":"Qin","year":"1988","journal-title":"Cancer"},{"key":"key20200713232400_b5-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/1097-0142(19810115)47:2<360::AID-CNCR2820470225>3.0.CO;2-3","article-title":"Nasopharyngeal carcinoma-a retrospective review of patients less than thirty years of age: A report of Children's cancer study group","volume":"47","author":"Jenkin","year":"1981","journal-title":"Cancer"},{"key":"key20200713232400_b6-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1279::AID-CNCR2>3.0.CO;2-C","article-title":"Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: Results of a matched cohort study","volume":"79","author":"Geara","year":"1997","journal-title":"Cancer"},{"key":"key20200713232400_b7-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/annonc\/mdt146","article-title":"Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials","volume":"24","author":"OuYang","year":"2013","journal-title":"Ann Oncol"},{"key":"key20200713232400_b8-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejca.2017.01.002","article-title":"Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial","volume":"75","author":"Chen","year":"2017","journal-title":"Eur J Cancer"},{"key":"key20200713232400_b9-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1158\/1078-0432.CCR-17-2656","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: Individual patient data pooled analysis of four randomized trials","volume":"24","author":"Chen","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20200713232400_b10-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<202::AID-CNCR3>3.0.CO;2-N","article-title":"Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis","volume":"78","author":"Chua","year":"1996","journal-title":"Cancer"},{"key":"key20200713232400_b11-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ejca.2015.10.068","article-title":"Is there any benefit to adding adjuvant chemotherapy after concurrent chemoradiotherapy for nasopharyngeal carcinoma?","volume":"56","author":"Yan","year":"2016","journal-title":"Eur J Cancer"},{"key":"key20200713232400_b12-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00066-014-0776-0","article-title":"Influence of dose and fractionation in intensity modulated re-irradiation of patients with relapse of nasopharyngeal carcinoma: A randomized phase II study","volume":"191","author":"Nieder","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"key20200713232400_b13-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.oraloncology.2015.11.015","article-title":"Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma","volume":"53","author":"Setton","year":"2016","journal-title":"Oral Oncol"},{"key":"key20200713232400_b14-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/clpt.2013.200","article-title":"Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer","volume":"95","author":"Solomon","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"key20200713232400_b15-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.ejca.2012.11.019","article-title":"Resistance to BRAF-targeted therapy in melanoma","volume":"49","author":"Sullivan","year":"2013","journal-title":"Eur J Cancer"},{"key":"key20200713232400_b16-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/ng.2913","article-title":"An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia","volume":"46","author":"Knoechel","year":"2014","journal-title":"Nat Genet"},{"key":"key20200713232400_b17-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"24750","DOI":"10.18632\/oncotarget.4990","article-title":"Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy","volume":"6","author":"Riquelme","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713232400_b18-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1160\/TH11-12-0875","article-title":"Deficiencies of antithrombin, protein C and protein S-practical experience in genetic analysis of a large patient cohort","volume":"108","author":"Caspers","year":"2012","journal-title":"Thromb Haemost"},{"key":"key20200713232400_b19-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0006-291X(83)90550-8","article-title":"Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity","volume":"116","author":"Choay","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713232400_b20-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/BF00852896","article-title":"Antithrombin III in children with various renal diseases","volume":"3","author":"Fukui","year":"1989","journal-title":"Pediatr Nephrol"},{"key":"key20200713232400_b21-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1160\/TH15-08-0687","article-title":"Antithrombin: Anti-inflammatory properties and clinical applications","volume":"115","author":"Levy","year":"2016","journal-title":"Thromb Haemost"},{"key":"key20200713232400_b22-mmr-19-05-3658","first-page":"191","article-title":"Antithrombin III activity in blood of patients with renal cancer","volume":"2","author":"Zietek","year":"1997","journal-title":"Pol Merkur Lekarski"},{"key":"key20200713232400_b23-mmr-19-05-3658","first-page":"268","article-title":"Activity of antithrombin III in the blood of patients with bladder cancer","volume":"2","author":"Zietek","year":"1997","journal-title":"Pol Merkur Lekarski"},{"key":"key20200713232400_b24-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1517\/14712598.2010.495713","article-title":"Pharmacology and clinical applications of human recombinant antithrombin","volume":"10","author":"Pal","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"key20200713232400_b25-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1442-200X.2011.03350.x","article-title":"Effects of antithrombin III treatment in vascular injury model of mice","volume":"53","author":"Maeda","year":"2011","journal-title":"Pediatr Int"},{"key":"key20200713232400_b26-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.2174\/138161282131151013190740","article-title":"RNA interference as a therapeutic strategy for the treatment of liver diseases","volume":"21","author":"Gonzalez-Rodriguez","year":"2015","journal-title":"Curr Pharm Des"},{"key":"key20200713232400_b27-mmr-19-05-3658","article-title":"American joint committee on cancer staging manual","author":"Amin","year":"2017","edition":"8th"},{"key":"key20200713232400_b28-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713232400_b29-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ng.601","article-title":"A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci","volume":"42","author":"Bei","year":"2010","journal-title":"Nat Genet"},{"key":"key20200713232400_b30-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5732\/cjc.010.10547","article-title":"Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"30","author":"Su","year":"2011","journal-title":"Chin J Cancer"},{"key":"key20200713232400_b31-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2407-10-39","article-title":"Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive cases","volume":"10","author":"Lin","year":"2010","journal-title":"BMC Cancer"},{"key":"key20200713232400_b32-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brachy.2012.08.002","article-title":"Long-term outcomes and prognostic factors in patients treated with intraoperatively planned prostate brachytherapy","volume":"12","author":"Vargas","year":"2013","journal-title":"Brachytherapy"},{"key":"key20200713232400_b33-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"e110765","DOI":"10.1371\/journal.pone.0110765","article-title":"Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma","volume":"9","author":"Tao","year":"2014","journal-title":"PLoS One"},{"key":"key20200713232400_b34-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12032-014-0170-x","article-title":"Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma","volume":"31","author":"Feng","year":"2014","journal-title":"Med Oncol"},{"key":"key20200713232400_b35-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/0974-1208.170407","article-title":"Prevalence and role of antithrombin III, protein C and protein S deficiencies and activated protein C resistance in Kosovo women with recurrent pregnancy loss during the first trimester of pregnancy","volume":"8","author":"Mekaj","year":"2015","journal-title":"J Hum Reprod Sci"},{"key":"key20200713232400_b36-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/00007890-199204000-00024","article-title":"The endothelial heparan sulfate-antithrombin III natural anticoagulant pathway in normal and transplanted human kidneys","volume":"53","author":"Absher","year":"1992","journal-title":"Transplantation"},{"key":"key20200713232400_b37-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"676","DOI":"10.5301\/tj.5000345","article-title":"Proteomic analysis of a nasopharyngeal carcinoma cell line and a nasopharyngeal epithelial cell line","volume":"101","author":"Huang","year":"2015","journal-title":"Tumori"},{"key":"key20200713232400_b38-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","article-title":"The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases","volume":"75","author":"Harper","year":"1993","journal-title":"Cell"},{"key":"key20200713232400_b39-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0092-8674(92)90244-7","article-title":"Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles","volume":"70","author":"Yin","year":"1992","journal-title":"Cell"},{"key":"key20200713232400_b40-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1074\/jbc.M207880200","article-title":"14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax","volume":"278","author":"Nomura","year":"2003","journal-title":"J Biol Chem"},{"key":"key20200713232400_b41-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.7314\/APJCP.2014.15.17.7065","article-title":"Mangiferin induces apoptosis by regulating Bcl-2 and Bax expression in the CNE2 nasopharyngeal carcinoma cell line","volume":"15","author":"Pan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200713232400_b42-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0","article-title":"Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors","volume":"92","author":"Satoh","year":"2001","journal-title":"Cancer"},{"key":"key20200713232400_b43-mmr-19-05-3658","first-page":"893","article-title":"Pharmacogenomic profiling of the PI3K\/PTEN-AKT-mTOR pathway in common human tumors","volume":"24","author":"Xu","year":"2004","journal-title":"Int J Oncol"},{"key":"key20200713232400_b44-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ctrv.2014.03.004","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in estrogen receptor-positive breast cancer","volume":"40","author":"Ciruelos Gil","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"key20200713232400_b45-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/01.ATV.0000143096.15099.ce","article-title":"PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice","volume":"24","author":"Schabbauer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20200713232400_b46-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/cns.12053","article-title":"Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K\/AKT\/caspase 3 pathway and anti-inflammatory responses","volume":"19","author":"Xu","year":"2013","journal-title":"CNS Neurosci Ther"},{"key":"key20200713232400_b47-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"20342","DOI":"10.1007\/s11356-017-9422-6","article-title":"Selenium protects against cadmium-induced kidney apoptosis in chickens by activating the PI3K\/AKT\/Bcl-2 signaling pathway","volume":"24","author":"Bao","year":"2017","journal-title":"Environ Sci Pollut Res Int"},{"key":"key20200713232400_b48-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"8661","DOI":"10.1007\/s13277-015-3626-5","article-title":"Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K\/AKT\/Bcl-2\/BAX pathway","volume":"36","author":"Sui","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713232400_b49-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"651207","DOI":"10.1155\/2013\/651207","article-title":"The role of EGFR\/PI3K\/Akt\/cyclinD1 signaling pathway in acquired middle ear cholesteatoma","volume":"2013","author":"Liu","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20200713232400_b50-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.canlet.2009.04.035","article-title":"Arsenic trioxide induces apoptosis and G2\/M phase arrest by inducing Cbl to inhibit PI3K\/Akt signaling and thereby regulate p53 activation","volume":"284","author":"Li","year":"2009","journal-title":"Cancer Lett"},{"key":"key20200713232400_b51-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1158\/0008-5472.CAN-09-4479","article-title":"Targeting fibroblast growth factor receptors blocks PI3K\/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis","volume":"70","author":"Dey","year":"2010","journal-title":"Cancer Res"},{"key":"key20200713232400_b52-mmr-19-05-3658","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s13402-015-0224-x","article-title":"PI3K\/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer","volume":"38","author":"Prasad","year":"2015","journal-title":"Cell Oncol (Dordr)"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:17:17Z","timestamp":1594685837000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2019.10021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":52,"URL":"https:\/\/doi.org\/10.3892\/mmr.2019.10021","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,14]]}}}